文献速递肾移植

淀粉样变性肾移植结局研究

Renal transplant outcomes in amyloidosis.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该回顾性队列研究比较了51例AL型和48例AA型系统性淀粉样变性肾移植患者与倾向评分匹配的ADPKD和糖尿病肾病患者的结局。AA和AL型淀粉样变性患者生存率与糖尿病肾病相当但低于ADPKD,死亡删失移植肾生存率各组相当。AL型中室间隔厚度>12mm和移植前血液学深度缓解显著影响患者生存。

要点

  • AA和AL型淀粉样变性肾移植患者生存率与糖尿病肾病相当但低于ADPKD
  • 死亡删失移植肾生存率在AA、AL、ADPKD和糖尿病肾病组间相当
  • AL型中室间隔厚度>12mm和移植前血液学深度缓解预测患者生存

核心结论

  • 经过选择的AA和AL型淀粉样变性患者肾移植结局与糖尿病肾病相当
  • AL型中室间隔厚度和移植前血液学深度缓解显著影响患者生存

研究设计与样本

  • 回顾性队列研究,纳入51例AL型和48例AA型系统性淀粉样变性肾移植患者
  • 采用倾向评分匹配生成匹配组,Kaplan-Meier分析比较生存,Cox比例风险分析评估预测因素

主要发现

  • AA型1年、5年、10年死亡删失移植肾生存率分别为94%、91%、78%,AL型分别为98%、93%、93%
  • AA型和AL型中位患者生存期分别为13.1年和7.9年
  • AL和AA型患者生存率与糖尿病肾病相当,但低于ADPKD(HR分别为3.12和3.09;P<0.001)
  • 死亡删失移植肾生存率各组间相当
  • AL型中室间隔舒张末期厚度>12mm预测死亡(HR=26.58;P=0.03),血液学深度缓解预测生存(HR=0.07;P=0.018)

临床怎么用

  • 对AA和AL型淀粉样变性患者进行肾移植评估时,可参考糖尿病肾病的预期结局
  • AL型患者移植前应评估室间隔厚度和实现血液学深度缓解以优化患者选择

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Outcomes after renal transplantation have traditionally been poor in systemic amyloid A (AA) amyloidosis and systemic light chain (AL) amyloidosis, with high mortality and frequent recurrent disease. We sought to compare outcomes with matched transplant recipients with autosomal dominant polycystic kidney disease (ADPKD) and diabetic nephropathy (DN), and identify factors predictive of outcomes. METHODS: We performed a retrospective cohort study of 51 systemic AL and 48 systemic AA amyloidosis patients undergoing renal transplantation. Matched groups were generated by propensity score matching. Patient and death-censored allograft survival were compared via Kaplan-Meier survival analyses, and assessment of clinicopathological features predicting outcomes via Cox proportional hazard analyses. RESULTS: One-, 5- and 10-year death-censored unadjusted graft survival was, respectively, 94, 91 and 78% for AA amyloidosis, and 98, 93 and 93% for AL amyloidosis; median patient survival was 13.1 and 7.9 years, respectively. Patient survival in AL and AA amyloidosis was comparable to DN, but poorer than ADPKD [hazard ratio (HR) = 3.12 and 3.09, respectively; P < 0.001]. Death-censored allograft survival was comparable between all groups. In AL amyloidosis, mortality was predicted by interventricular septum at end diastole (IVSd) thickness >12 mm (HR = 26.58; P = 0.03), while survival was predicted by haematologic response (very good partial or complete response; HR = 0.07; P = 0.018). In AA amyloidosis, recurrent amyloid was associated with elevated serum amyloid A concentration but not with outcomes. CONCLUSIONS: Renal transplantation outcomes for selected patients with AA and AL amyloidosis are comparable to those with DN. In AL amyloidosis, IVSd thickness and achievement of deep haematologic response pre-transplant profoundly impact patient survival.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Law S, Cohen O, Lachmann HJ, et al. Renal transplant outcomes in amyloidosis. Nephrol Dial Transplant. 2021. PMID: 33439995. doi:10.1093/ndt/gfaa293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。